Search

everythinglearnresearchcommunity

for

Search:↓

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Finasteride doesn't affect ovulation in normal women.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Diet changes hormone levels in pregnant ewes by affecting metabolism, not placental synthesis.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Finasteride potentially treats hair loss by reducing DHT production.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Lower SHBG levels may increase the risk of PCOS.

Male hormones worsen kidney transplant damage, but blocking them helps.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Compound 4 is a promising treatment for hair loss with low toxicity.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.